pRecLV105 MEF2C Citations (1)
Originally described in: MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia.Brown FC, Still E, Koche RP, Yim CY, Takao S, Cifani P, Reed C, Gunasekera S, Ficarro SB, Romanienko P, Mark W, McCarthy C, de Stanchina E, Gonen M, Seshan V, Bhola P, O'Donnell C, Spitzer B, Stutzke C, Lavallee VP, Hebert J, Krivtsov AV, Melnick A, Paietta EM, Tallman MS, Letai A, Sauvageau G, Pouliot G, Levine R, Marto JA, Armstrong SA, Kentsis A Cancer Discov. 2018 Apr;8(4):478-497. doi: 10.1158/2159-8290.CD-17-1271. Epub 2018 Feb 5. PubMed Journal
Articles Citing pRecLV105 MEF2C
| Articles |
|---|
| Menin-dependent megakaryocyte proliferation and fibrosis in myeloproliferative neoplasms. Wen J, Cotton A, Mehmood R, Mohan M, Hall T, Broadhurst AL, Zhang K, Olufadi Y, Kang G, Marcellino B, Mascarenhas J, Hoffman R, Janke LJ, Gurbuxani S, McGeehan GM, Crispino JD. Cancer Cell. 2026 Aug 10;44(8):1639-1652.e6. doi: 10.1016/j.ccell.2026.06.008. Epub 2026 Jul 9. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.